STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma.
Ito N, Eto M, Nakamura E, Takahashi A, Tsukamoto T, Toma H, Nakazawa H, Hirao Y, Uemura H, Kagawa S, Kanayama H, Nose Y, Kinukawa N, Nakamura T, Jinnai N, Seki T, Takamatsu M, Masui Y, Naito S, Ogawa O.
Ito N, et al. Among authors: nose y.
J Clin Oncol. 2007 Jul 1;25(19):2785-91. doi: 10.1200/JCO.2006.09.8897.
J Clin Oncol. 2007.
PMID: 17602083